respiratory-995x60.png respiratory-995x60.png

FEATURED ARTICLES

A Relationship Driven By Technology:  How Sponsors And CROs Can Improve Collaboration
A Relationship Driven By Technology: How Sponsors And CROs Can Improve Collaboration

The typical relationship between clinical trial sponsors and CROs is rarely described as ‘simple.’ And few, if any, are based on the trust and collaboration that would improve efficiencies in clinical research. With over 70% of clinical trials being outsourced to CROs, and less than 10% meeting trial completion dates, the question becomes not when, but how can this critical relationship be improved to make clinical development more efficient?

More Featured Articles

WHITE PAPERS AND CASE STUDIES

  • SynteractHCR Full-Service CRO Brochure

    SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

  • Treating Cystic Fibrosis: An Evaluation Of Aeroquin®, A New Aerosolized Form Of Levofloxacin

    SynteractHCR is a privately held contract research organization (CRO) dedicated to meeting the needs of biotech, pharmaceutical and medical device companies.

  • MedicINova Changes CROs During Phase II Asthma Trial

    SynteractHCR, Inc. was sought out by sponsor MediciNova, a publicly traded biopharmaceutical company headquartered in San Diego, for assistance on a Phase 2 asthma trial, MN-221 Cl-007: A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of MN-221 in adults with acute exacerbations of asthma.

  • Chronic Obstructive Pulmonary Disease (COPD) Research

    As of 2015, InVentiv Health has completed over 70 Phase I-IV respiratory studies of various types – including those involving allergy, asthma, COPD, and cystic fibrosis. That experience has given them significant insight in overcoming the typical logistical and clinical challenges sponsors are normally faced with when conducting respiratory studies.

More White Papers & Case Studies

NEWS

More News